Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection

Bibliographic Details
Main Authors:	Paulina Konrad, Jan Chojnacki, Anita Gąsiorowska, Cezary Rudnicki, Aleksandra Kaczka, Cezary Chojnacki
Format:	Article
Language:	English
Published:	Termedia Publishing House 2018-03-01
Series:	Gastroenterology Review
Subjects:	small intestinal bacterial overgrowth <i>Helicobacter pylori</i> therapy rifaximin amoxicillin
Online Access:	https://www.termedia.pl/Therapeutic-efficacy-of-amoxicillin-and-rifaximin-in-patients-with-small-intestinal-bacterial-overgrowth-and-Helicobacter-pylori-infection,41,32191,1,1.html

Similar Items

Serotonin Pathway of Tryptophan Metabolism in Small Intestinal Bacterial Overgrowth—A Pilot Study with Patients Diagnosed with Lactulose Hydrogen Breath Test and Treated with Rifaximin
by: Cezary Chojnacki, et al.
Published: (2021-05-01)

Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran
by: Farzad Khademi, et al.
Published: (2013-01-01)

Amoxicillin and Clarithromycin Mucoadhesive Delivery System for <i>Helicobacter pylori</i> Infection in a Mouse Model: Characterization, Pharmacokinetics, and Efficacy
by: Isabel Villegas, et al.
Published: (2021-01-01)

Effects of <i>Lactobacillus salivarius</i> LN12 in Combination with Amoxicillin and Clarithromycin on <i>Helicobacter pylori</i> Biofilm In Vitro
by: Fang Jin, et al.
Published: (2021-07-01)

Efficacy of and Resistance to Rifaximin-based Quadruple Therapy in Eradication
by: Hyun Soo Kim, et al.
Published: (2020-09-01)

Genetic and Transcriptomic Variations for Amoxicillin Resistance in <i>Helicobacter pylori</i> under Cryopreservation
by: Xiurui Han, et al.
Published: (2021-05-01)

Comparison of amoxicillin and metronidazole effect on three-drug regimen for the treatment of Helicobacter pylori infection in children
by: Karam-Ali Kasiri, et al.
Published: (2017-01-01)

RESISTANCE TO AMOXICILLIN, CLARITHROMYCIN AND CIPROFLOXACIN OF Helicobacter pylori ISOLATED FROM SOUTHERN BRAZIL PATIENTS
by: Simone Ulrich Picoli, et al.
Published: (2014-06-01)

Deteksi Resistensi Amoxicillin Helicobacter pylori pada Pasien Dispepsia
by: Indah Sulistiyawati, et al.
Published: (2017-08-01)

Efficacy of rifaximine in intestinal bacterial overgrowth syndrome in patients after cholecystectomy
by: Tat'yana Anatol'evna Mechetina, et al.
Published: (2011-12-01)

Gastric histopathological features after the administration of omeprazole, amoxicillin, and clarithromycin in gastritis Helicobacter pylori rat model
by: OK Yulizal, et al.
Published: (2021-03-01)

Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013–2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)
by: Luis Bujanda, et al.
Published: (2021-09-01)

Eradication of Helicobacter pylori with triple therapy regimen (omeprazole, clarithromycin and amoxicillin) in children for seven days (A Pilot Study)
by: Mehri Najafi, et al.
Published: (2014-07-01)

Eradication of Helicobacter pylori with triple therapy regimen (omeprazole, clarithromycin and amoxicillin) in children for seven days (A Pilot Study)
by: Mehri Najafi, et al.
Published: (2014-07-01)

Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of <i>Helicobacter pylori</i>
by: Hasan Salman, et al.
Published: (2010-01-01)

Enhanced Antibacterial Potential of Amoxicillin against <i>Helicobacter pylori</i> Mediated by Lactobionic Acid Coated Zn-MOFs
by: Haseena, et al.
Published: (2021-09-01)

Antimicrobial resistance of Helicobacter pylori in Smolensk
by: Dekhnich N.N., et al.
Published: (2018-02-01)

Biofilm Formation and Antibiotic Resistance Phenotype of<i> Helicobacter pylori </i>Clinical Isolates
by: Kartika Afrida Fauzia, et al.
Published: (2020-07-01)

Current prevalence of Helicobacter pylori infection in patients with dyspepsia treated in Warsaw, Poland
by: Tadeusz Tacikowski, et al.
Published: (2017-05-01)

The efficiency of rifaximin in the correction of the small intestinal bacterial overgrowth syndrome in chronic inflammatory bowel diseases and functional bowel disorders
by: Yu.M. Stepanov, et al.
Published: (2019-11-01)

Comparison of Ten-Day Sequential and Standard Triple Therapy for Helicobacter pylori Eradication
by: Behdad Ravarian, et al.
Published: (2019-07-01)

The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study
by: Sebahat Basyigit, et al.
Published: (2015-10-01)

Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey
by: Reyhan Caliskan, et al.
Published: (2015-06-01)

Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers
by: Fernando Marcuz Silva, et al.
Published: (2015-05-01)

Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan
by: Kageyama C, et al.
Published: (2019-03-01)

Clinical experience with the use of the intestinal antibiotic Rifaximin for celiac disease
by: L. S. Оrеshkо, et al.
Published: (2019-10-01)

Effect of bismuth addition to the triple therapy of Helicobacter pylori eradication
by: Ezel Taşdemir, et al.
Published: (2012-03-01)

Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial Erradicação de Helicobacter pylori com o uso de tetraciclina e furazolidona versus amoxicilina e azitromicina em terapia tríplice com lansoprazol
by: Laura Cidrão Frota, et al.
Published: (2005-06-01)

Rifabutin for the Treatment of <i>Helicobacter Pylori</i> Infection: A Review
by: Javier P. Gisbert
Published: (2021-12-01)

Susceptibility to rifaximin and other antimicrobial agents of bacteria isolated from acute gastrointestinal infections in Mexico
by: O. Novoa-Farías, et al.
Published: (2016-01-01)

The Effects of Sulglycotide on the Adhesion and the Inflammation of <i>Helicobacter Pylori</i>
by: Ji Yeong Yang, et al.
Published: (2020-04-01)

<i>Helicobacter pylori</i> Infection and Psoriasis: A Systematic Review and Meta-Analysis
by: Mingyang Yu, et al.
Published: (2019-09-01)

Aromatherapy in the treatment of rosacea induced by Helicobacter pylori
by: Robert Walaszek, et al.
Published: (2019-06-01)

Gastric Microbiota in <i>Helicobacter pylori</i>-Negative and -Positive Gastritis Among High Incidence of Gastric Cancer Area
by: Boldbaatar Gantuya, et al.
Published: (2019-04-01)

Role of <i>Helicobacter pylori</i> and Other Environmental Factors in the Development of Gastric Dysbiosis
by: Uriel Gomez-Ramirez, et al.
Published: (2021-09-01)

The importance of probiotics in optimizing the efficacy and safety of <i>Helicobacter pylori</i> infection eradication therapy
by: D. N. Andreev, et al.
Published: (2020-05-01)

"Effect of one week furazolidone in combination with amoxicillin, bismuth subcitrate and omperazole on eradication of Helicobacter pylori "
by: Salman Roghani H, et al.
Published: (2007-04-01)

The Role of Statins on <em>Helicobacter pylori</em> Eradication: Results from the European Registry on the Management of <em>H. pylori</em> (Hp-EuReg)
by: María Caldas, et al.
Published: (2021-08-01)

Genetics of Host Protection against <i>Helicobacter pylori</i> Infections
by: Rosanna Capparelli, et al.
Published: (2021-03-01)

Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome
by: Xiaojun Zhuang, et al.
Published: (2020-06-01)

Cannot write session to /tmp/vufind_sessions/sess_eoa14k1kkal40jle9869csbate